EWTX Earnings

Quarterly EPS
$-0.36
Q3 2024
$-0.42
Q4 2024
$-0.43
Q1 2025
$-0.34
Q2 2025
$-0.39
Q3 2025
$-0.47
Q4 2025
$-0.46
Q1 2026
$-0.53
Q2 2026
Latest RevenueN/A
Latest Net Income-57327000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.530-57327000-55.9%
Q1 2026-$0.460-49013000-7.0%
Q4 2025-$0.470-50216000-11.9%
Q3 2025-$0.390-40666000-8.3%
Q2 2025-$0.340-36115000+0.0%
Q1 2025-$0.430-40798000-30.3%
Q4 2024-$0.420-39662000+10.6%
Q3 2024-$0.360-34129000+12.2%
Q2 2024-$0.340-31497000
Q1 2024-$0.330-28525000
Q4 2023-$0.470-30143000
Q3 2023-$0.410-25713000
Edgewise Therapeutics (EWTX) — Earnings